Representation of American blacks in clinical trials of new drugs

C. K. Svensson
Department of Pharmaceutical Sciences, College of Pharmacy, Wayne State University, Detroit, MI 48202.

Investigations that have revealed racial differences in drug response and disposition indicate the need for adequate representation of racial minorities in clinical drug trials. There is concern, however, that there may be a disproportionate use of racial and ethnic minorities in clinical research due to the inner city location of most university hospitals. To examine this issue, we reviewed the representation of American blacks in 50 recently published clinical trials of new drugs. This survey revealed that investigators do not seem to adequately take into account racial differences as a potential source of variability. It also was found that in the majority of studies, the proportion of black subjects is less than their proportion in the general population. This underrepresentation in clinical trials suggests that insufficient data exist to accurately assess the safety and efficacy of many new drugs in American blacks.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Population Issues in Clinical Trials
Mosenifar
Proc Am Thorac Soc 2007;4:185-188.
ABSTRACT | FULL TEXT  

Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer
Moy et al.
Ann Oncol 2006;17:1637-1643.
ABSTRACT | FULL TEXT  

Recruiting Minority Men Who Have Sex With Men for HIV Research: Results From a 4-City Campaign
Silvestre et al.
Am. J. Public Health 2006;96:1020-1027.
ABSTRACT | FULL TEXT  

Importance of Race/Ethnicity in Clinical Trials: Lessons From the African-American Heart Failure Trial (A-HeFT), the African-American Study of Kidney Disease and Hypertension (AASK), and the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
Taylor et al.
Circulation 2005;112:3654-3666.
FULL TEXT  

Recruitment of ethnic minorities to asthma studies * Authors' reply
van der Wouden et al.
Thorax 2005;60:257-257.
FULL TEXT  

Ethnic Minority Older Adults Participating in Clinical Research: Developing Trust
Moreno-John et al.
J Aging Health 2004;16:93S-123S.
ABSTRACT  

The Effectiveness of an Advance Notice Letter on the Recruitment of African Americans and Whites for a Mailed Patient Satisfaction Survey
Napoles-Springer et al.
J Aging Health 2004;16:124S-136S.
ABSTRACT  

Engaging High-Risk Populations in Community-Level Fitness Promotion: ROCK! Richmond
Yancey et al.
Health Promot Pract 2003;4:180-188.
ABSTRACT  

Recruitment of Older African Americans for Survey Research: A Process Evaluation of the Community and Church-Based Strategy in the Durham Elders Project
Reed et al.
Gerontologist 2003;43:52-61.
ABSTRACT | FULL TEXT  

Representation of the Elderly, Women, and Minorities in Heart Failure Clinical Trials
Heiat et al.
Arch Intern Med 2002;162:1682-1688.
ABSTRACT | FULL TEXT  

Participation in Research and Access to Experimental Treatments by HIV-Infected Patients
Gifford et al.
NEJM 2002;346:1373-1382.
ABSTRACT | FULL TEXT  

Racial Disparities in Clinical Trials
King
NEJM 2002;346:1400-1402.
FULL TEXT  

Clinical Research with Older African Americans and Latinos: Perspectives from the Community
Napoles-Springer et al.
Research on Aging 2000;22:668-691.
ABSTRACT  

Cerebrovascular Disease in African Americans
Gorelick
Stroke 1998;29:2656-2664.
FULL TEXT  

Expanding Prisoners' Access to AIDS-Related Clinical Trials: An Ethical and Clinical Imperative
KELLY
The Prison Journal 1995;75:48-68.
ABSTRACT  

Community-Based AIDS Research
Merton
Eval Rev 1990;14:502-537.
ABSTRACT